10x Genomics (TXG) Change in Acquisitions & Divestments (2022 - 2026)

10x Genomics has disclosed Change in Acquisitions & Divestments across 5 years of filings, most recently posting $25.0 million for Q2 2026.

• In Q2 2026, Change in Acquisitions & Divestments fell 50.0% year-over-year to $25.0 million; the TTM figure through Jun 2026 stood at $125.2 million (up 150.4% YoY), while the FY2025 annual figure was $125.2 million, up 385.61% from the prior year.
• Change in Acquisitions & Divestments came in at $25.0 million for Q2 2026 at 10x Genomics, roughly flat from $25.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $93.3 million in Q1 2023 to a low of $1.2 million in Q3 2023.
• Average Change in Acquisitions & Divestments over 5 years is $23.4 million, with a median of $13.0 million recorded in 2024.
• Year-over-year, Change in Acquisitions & Divestments plunged 91.99% in 2023 and surged 698.01% in 2024.
• Over 5 years, Change in Acquisitions & Divestments stood at $7.7 million in 2022, then slumped by 47.46% to $4.1 million in 2023, then jumped by 215.93% to $12.8 million in 2024, then jumped by 96.75% to $25.2 million in 2025, then retreated by 0.79% to $25.0 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $25.0 million in Q2 2026, $25.0 million in Q1 2026, and $25.2 million in Q4 2025.